• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
Geriatrics

Geriatrics

Ethnogeriatrics

  • Facebook
  • Twitter
  • YouTube
  • Home
  • Culture Med
    • Ethnogeriatrics Overview
      • Introduction
      • Patterns of Health Risk
      • Fund of Knowledge
      • Assessment
      • Delivery of Care
    • Glossary
    • Interview Strategies
  • Ethno Med
    • Background
    • African American
    • Alaska Native
    • American Indian
    • Asian Indian American
    • Chinese American
    • Filipino American
    • Hawaiian and Pacific Islander
    • Hispanic / Latino American
    • Hmong American
    • Japanese American
    • Korean American
    • Pakistani American
    • Vietnamese American
  • Medical Interpreters
    • Microlectures
    • Partnering with medical interpreter
  • Training
  • Media Coverage
  • About Us
    • Overview
    • SAGE Certificate Program
    • iSAGE Team
    • Contact iSAGE
    • Aging Adult Services at Stanford
    • System Requirements

Cancer

“Understanding the causes of ethnic differences in cytotoxic metabolism may promote improved and more individualised prescribing, as well as culturally competent prescribing.”

Cancer rates vary with age, acculturation and location. Some of these differences may represent the influence of environment, such as diet and health habits, and therefore may be modifiable. (National Cancer Institute Registry: https://seer.cancer.gov/ Concomitantly, genetics may play a role as well. There is wide inter-individual variability in the pharmacokinetics, pharmacodynamics and tolerance of anticancer drugs.

Recent evidence suggests that there is even greater variability between individuals of different ethnicity. Allelic variants of genes encoding drug metabolising enzymes are expressed with different incidences in different ethnic groups, particularly between Asian and Caucasians, and some of these variants result in altered enzyme function.

There is also preliminary evidence to suggest that ethnic differences in the expression of allelic variants may produce altered pharmacokinetics of anticancer drugs, including paclitaxel and irinotecan. Emerging evidence indicates that toxicity from certain anticancer treatments is much greater in Asian patients than Caucasians in breast and lung cancers. Understanding the causes of ethnic differences in cytotoxic metabolism may promote improved and more individualised prescribing, as well as culturally competent prescribing. (Phan 2009)

    Pages:
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6

Primary Sidebar

Culturemed Image

Chinese American

  • Description
  • Learning Objectives
  • Introduction and Overview
    • Current Population
    • Religion
    • Language
  • Patterns of Health Risk
    • Role of Western Society
    • Depression
    • Alcoholism
    • Dementia
    • Infectious Disease
    • Cancer
      • Liver Cancer
      • NPC
      • Breast Cancer
      • Prostate Cancer
      • Colon Cancer
      • Lung Cancer
    • Smoking
    • Cardiovascular Disease
    • Diabetes
    • ESRD

Culturally Appropriate Care

  • Fund of Knowledge
    • Beliefs and Practices
      • Confucianism
      • Other Influences
      • Conflicts with Western Autonomy
    • Cohort Analysis
      • Historical Influence
      • Significant Dates and Periods
    • Acculturation
  • Assessment
    • Heterogeneity vs. Homogeneity
    • Degree of Acculturation and Traditional Beliefs
  • Delivery of Care
    • Health Care Provider Role
    • Traditional Chinese Medicine
    • Psychotherapy
    • Advance Directives/End of Life Issues
    • Medications
  • Cancer Care

Access & Utilization

  • Health Care Utilization
  • Long Term Care

Learning Resources

  • Instructional Strategies
    • Case Study 1
    • Case Study 2
  • Student Evaluation
  • Links
  • List of References
  • Searchable Reference Database
  • Glossary
  • Interview Strategies
© 2019 Stanford Medicine
Privacy Policy • Terms of Use